IMVT
Immunovant·NASDAQ
--
--(--)
--
--(--)
IMVT Filings
Filing Date
Form Description
Form Type
2026-02-06
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript
Earnings Call
2026-02-06 · Earnings Call
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript
2026-02-06
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2026-02-06 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026-02-06
Form 8-K - Current report
Key Events
2026-02-06 · Key Events
Form 8-K - Current report
2026-01-23
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-23 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-12
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-12-12 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-12-12
Form 8-K - Current report
Key Events
2025-12-12 · Key Events
Form 8-K - Current report
2025-12-12
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-12 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-11
Form 8-K - Current report
Key Events
2025-12-11 · Key Events
Form 8-K - Current report
